ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 754110 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 754110; 2) Community: the network communities that were significantly associated with the response to NSC 754110; 3) Molecule: the relationships between components within communities and NSC 754110; 4) MDR: the compounds that were significantly associated with the NSC 754110.

NSC Compound Enrichment Correlation
NSC 330500 Macbecin II 0.0376362543535812 0.31846584
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0376362543535812 0.26517368
NSC 363812 Tetraplatin 0.0376362543535812 0.36409441
NSC 603553 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-methoxy phenyl)-, hydrochloride 0.0376362543535812 0.15882728
NSC 610458 Camptothecin Derivative 0.0376362543535812 0.12590186
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0376362543535812 0.25858704
NSC 621335 Null 0.0376362543535812 0.14723993
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.0376362543535812 0.37898714
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0376362543535812 0.12035756
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0376362543535812 0.43430918
Total:96  Current:73    [First] [Prev] [Next] [Last]